臺大學術典藏 |
2021-09-04T06:11:10Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; JIA-HORNG KAO; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
臺大學術典藏 |
2021-05-27T08:21:00Z |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies
|
JYH-MING LIOU; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; Wu M.-S.; Lin J.-T. |
臺大學術典藏 |
2021-05-27T08:20:51Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
JYH-MING LIOU; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
臺大學術典藏 |
2021-03-18T02:03:40Z |
Helicobacter pylori-seronegative gastric carcinoma: A subset of gastric carcinoma with distinct clinicopathologic features
|
Wu M.-S.; Hung H.-W.; Wang J.-T.; Tseng C.-C.; CHIA-TUNG SHUN; Wang H.-P.; Lee W.-J.; Lin J.-T. |
臺大學術典藏 |
2021-03-18T02:02:38Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
臺大學術典藏 |
2021-02-26T02:00:05Z |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies
|
Liou J.-M.; Chang C.-Y.; WANG-HUEI SHENG; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; Wu M.-S.; Lin J.-T. |
臺大學術典藏 |
2021-02-18T08:38:06Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chieh-Chang Chen; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
臺大學術典藏 |
2021-02-02T05:45:33Z |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies
|
Liou J.-M.; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; YI-CHIA LEE; Hung H.-W.; Chian H.; Chang S.-C.; Wu M.-S.; Lin J.-T. |
臺大學術典藏 |
2021-02-02T05:45:19Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.;Bair M.-J.;Chen C.-C.;Yi-Chia Lee;Chen M.-J.;Chen C.-C.;Tseng C.-H.;Fang Y.-J.;Lee J.-Y.;Yang T.-H.;Luo J.-C.;Wu J.-Y.;Chang W.-H.;Chang C.-C.;Chen C.-Y.;Chen P.-Y.;Shun C.-T.;Hsu W.-F.;Hung H.-W.;Lin J.-T.;Chang C.-Y.;Wu M.-S.; Liou J.-M.; Bair M.-J.; Chen C.-C.; YI-CHIA LEE; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
臺大學術典藏 |
2021-02-02T02:24:42Z |
Helicobacter pylori-seronegative gastric carcinoma: A subset of gastric carcinoma with distinct clinicopathologic features
|
MING-SHIANG WU; Hung H.-W.; Wang J.-T.; Tseng C.-C.; Shun C.-T.; Wang H.-P.; Lee W.-J.; Lin J.-T. |
臺大學術典藏 |
2021-02-02T02:21:46Z |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies
|
Liou J.-M.; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; MING-SHIANG WU; Lin J.-T. |
臺大學術典藏 |
2021-02-02T02:21:14Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU |
臺大學術典藏 |
2021-02-02T02:21:10Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
臺大學術典藏 |
2021-01-15T03:52:49Z |
Helicobacter pylori-seronegative gastric carcinoma: A subset of gastric carcinoma with distinct clinicopathologic features
|
Wu M.-S.; Hung H.-W.; Wang J.-T.; Tseng C.-C.; Shun C.-T.; HSIU-PO WANG; Lee W.-J.; Lin J.-T. |
臺大學術典藏 |
2020-11-27T03:28:38Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
臺大學術典藏 |
2020-11-27T03:28:38Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; CHIEH-CHANG CHEN; Lee Y.-C.; Chen M.-J.; Chien-Chuan Chen; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
臺大學術典藏 |
2020-11-02T02:04:53Z |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies
|
Lin J.-T.; Liou J.-M.; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; MING-SHIANG WU |
臺大學術典藏 |
2020-11-02T02:04:26Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen�VNegative Patients
|
Lin J.-T.; Wu C.-Y.; Hung H.-W.; Fang Y.-J.; Chen C.-C.; Chiang M.-F.; Wang C.-S.; Yang T.-H.; Wang W.-L.; Kao J.-H.; MING-SHIANG WU; Chang C.-Y.; Hsu Y.-C.; Mo L.-R. |
臺大學術典藏 |
2020-06-11T07:06:11Z |
4?25 Gb/s transceiver with optical front-end for 100 GbE system in 65 nm CMOS technology
|
Chiang, P.-C.;Jiang, J.-Y.;Hung, H.-W.;Wu, C.-Y.;Chen, G.-S.;Lee, J.; Chiang, P.-C.; Jiang, J.-Y.; Hung, H.-W.; Wu, C.-Y.; Chen, G.-S.; Lee, J.; JRI LEE |
臺大學術典藏 |
2020-06-11T07:06:07Z |
100Gb/s ethernet chipsets in 65nm CMOS technology
|
Jiang, J.-Y.;Chiang, P.-C.;Hung, H.-W.;Lin, C.-L.;Yoon, T.;Lee, J.; Jiang, J.-Y.; Chiang, P.-C.; Hung, H.-W.; Lin, C.-L.; Yoon, T.; Lee, J.; JRI LEE |
臺大學術典藏 |
2020-06-11T07:06:07Z |
A 40Gb/s TX and RX chip set in 65nm CMOS
|
Chen, M.-S.;Shih, Y.-N.;Lin, C.-L.;Hung, H.-W.;Lee, J.; Chen, M.-S.; Shih, Y.-N.; Lin, C.-L.; Hung, H.-W.; Lee, J.; JRI LEE |
臺大學術典藏 |
2020-06-11T07:06:07Z |
60Gb/s NRZ and PAM4 transmitters for 400GbE in 65nm CMOS
|
Chiang, P.-C.;Hung, H.-W.;Chu, H.-Y.;Chen, G.-S.;Lee, J.; Chiang, P.-C.; Hung, H.-W.; Chu, H.-Y.; Chen, G.-S.; Lee, J.; JRI LEE |
臺大學術典藏 |
2020-06-11T07:06:04Z |
Fully-integrated 40-Gb/s pulse pattern generator and bit-error-rate tester chipsets in 65-nm CMOS technology
|
Chen, G.-S.;Wu, C.-Y.;Lin, C.-L.;Hung, H.-W.;Lee, J.; Chen, G.-S.; Wu, C.-Y.; Lin, C.-L.; Hung, H.-W.; Lee, J.; JRI LEE |
臺大學術典藏 |
2020-06-11T06:37:35Z |
Silicon-nanocrystal resonant-cavity light-emitting devices for color tailoring
|
Tseng, C.K.;Hung, H.W.;Huang, J.R.;Lee, K.Y.;Lin, G.R.;Shieh, J.M.;Lee, M.C.M.; Tseng, C.K.; Hung, H.W.; Huang, J.R.; Lee, K.Y.; Lin, G.R.; Shieh, J.M.; Lee, M.C.M.; GONG-RU LIN |
臺大學術典藏 |
2019-09-02T08:58:36Z |
Helicobacter pylori-seronegative gastric carcinoma: A subset of gastric carcinoma with distinct clinicopathologic features
|
Lin J.-T.;Lee W.-J.;Wang H.-P.;Shun C.-T.;Tseng C.-C.;Wang, Jin-Town;Hung H.-W.;Wu M.-S.; Wu M.-S.; Hung H.-W.; Wang, Jin-Town; Tseng C.-C.; Shun C.-T.; Wang H.-P.; Lee W.-J.; Lin J.-T. |